Asarina

Asarina Pharma AB is a Swedish biotechnology company focused on developing Sepranolone (UC1010) for the treatment of premenstrual dysphoric disorder (PMDD) and other menstrual-related conditions. The company's primary goal is to provide a new therapy specifically designed for PMDD. Asarina has a second-generation oral compound in preclinical development for PMDD.